Capital World Investors Catalent, Inc. Transaction History

Capital World Investors

$625 Billion
Q3 2024

A detailed history of Capital World Investors transactions in Catalent, Inc. stock. As of the latest transaction made, Capital World Investors holds 6,398,483 shares of CTLT stock, worth $378 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

6,398,483

Previous 4,911,723 30.27%

Holding current value

$378 Million

Previous $276 Million 40.32%

% of portfolio

0.06%

Previous 0.05%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$56.16 - $60.96 $83.5 Million - $90.6 Million	1,486,760 Added 30.27%	6,398,483 $388 Million
Q2 2024 Aug 13, 2024	SELL	$53.58 - $57.02 $429 Million - $457 Million	-8,012,698 Reduced 62.0%	4,911,723 $276 Million
Q1 2024 May 14, 2024	SELL	$42.56 - $59.82 $262 Million - $368 Million	-6,155,573 Reduced 32.26%	12,924,421 $730 Million
Q4 2023 Feb 13, 2024	BUY	$32.18 - $46.57 $35.3 Million - $51.2 Million	1,098,474 Added 6.11%	19,079,994 $857 Million
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $89.3 Million - $101 Million	2,021,185 Added 12.66%	17,981,520 $819 Million
Q2 2023 Aug 11, 2023	BUY	$31.86 - $67.26 $81.5 Million - $172 Million	2,556,699 Added 19.07%	15,960,335 $692 Million
Q1 2023 May 15, 2023	SELL	$45.44 - $74.26 $18.8 Million - $30.7 Million	-413,567 Reduced 2.99%	13,403,636 $881 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $99.7 Million - $195 Million	2,407,795 Added 21.1%	13,817,203 $622 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $80.3 Million - $125 Million	1,109,522 Added 10.77%	11,409,408 $826 Million
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $137 Million - $179 Million	1,565,516 Added 17.92%	10,299,886 $1.11 Billion
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $166 Million - $220 Million	-1,765,930 Reduced 16.82%	8,734,370 $969 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $15.7 Million - $18.3 Million	-131,704 Reduced 1.24%	10,500,300 $1.34 Billion
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $111 Million - $145 Million	1,018,902 Added 10.6%	10,632,004 $1.41 Billion
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $311 Million - $359 Million	3,101,236 Added 47.62%	9,613,102 $1.04 Billion
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $112 Million - $138 Million	1,104,543 Added 20.43%	6,511,866 $686 Million
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $464 Million - $570 Million	5,407,323 New	5,407,323 $563 Million

Others Institutions Holding CTLT

# of Institutions

513

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Catalent, Inc. Transaction History